{"bill":{"bill_id":1372345,"change_hash":"ce1cc335e2d0f9afe7e0cc6b9465a271","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/SB4134\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/senate-bill\/4134\/all-info","completed":0,"status":1,"status_date":"2020-07-01","progress":[{"date":"2020-07-01","event":1},{"date":"2020-07-01","event":9}],"state":"US","state_id":52,"bill_number":"SB4134","bill_type":"B","bill_type_id":"1","body":"S","body_id":115,"current_body":"S","current_body_id":115,"title":"Increasing Access to Biosimilars Act of 2020","description":"Requires the Centers for Medicare & Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the cost if the provider had furnished the underlying reference biological product instead.","pending_committee_id":2326,"committee":{"committee_id":2326,"chamber":"S","chamber_id":115,"name":"Finance"},"referrals":[{"date":"2020-07-01","committee_id":2326,"chamber":"S","chamber_id":115,"name":"Finance"}],"history":[{"date":"2020-07-01","action":"Read twice and referred to the Committee on Finance.","chamber":"S","chamber_id":115,"importance":1}],"sponsors":[{"people_id":9444,"person_hash":"0ie58qto","party_id":"2","state_id":52,"party":"R","role_id":2,"role":"Sen","name":"John Cornyn","first_name":"John","middle_name":"","last_name":"Cornyn","suffix":"","nickname":"","district":"SD-TX","ftm_eid":6646197,"votesmart_id":15375,"opensecrets_id":"N00024852","knowwho_pid":211675,"ballotpedia":"John_Cornyn","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":9463,"person_hash":"ldf3b0fy","party_id":"1","state_id":52,"party":"D","role_id":2,"role":"Sen","name":"Michael Bennet","first_name":"Michael","middle_name":"F.","last_name":"Bennet","suffix":"","nickname":"","district":"SD-CO","ftm_eid":5995587,"votesmart_id":110942,"opensecrets_id":"N00030608","knowwho_pid":274906,"ballotpedia":"Michael_Bennet","sponsor_type_id":2,"sponsor_order":2,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":19499,"person_hash":"xk4y3m3y","party_id":"1","state_id":52,"party":"D","role_id":2,"role":"Sen","name":"Tina Smith","first_name":"Tina","middle_name":"","last_name":"Smith","suffix":"","nickname":"","district":"SD-MN","ftm_eid":4173995,"votesmart_id":152968,"opensecrets_id":"N00042353","knowwho_pid":332335,"ballotpedia":"Tina_Smith","sponsor_type_id":2,"sponsor_order":3,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":8,"type":"Related","sast_bill_number":"HB6179","sast_bill_id":1358567}],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13146,"subject_name":"Congressional oversight"},{"subject_id":22688,"subject_name":"Government studies and investigations"},{"subject_id":13206,"subject_name":"Health care costs and insurance"},{"subject_id":13210,"subject_name":"Health information and medical records"},{"subject_id":13212,"subject_name":"Health programs administration and funding"},{"subject_id":13242,"subject_name":"Medicare"},{"subject_id":13490,"subject_name":"Prescription drugs"}],"texts":[{"doc_id":2200930,"date":"2020-07-16","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/SB4134\/id\/2200930","state_link":"https:\/\/www.congress.gov\/116\/bills\/s4134\/BILLS-116s4134is.pdf","text_size":309860,"text_hash":"4638092b94967093910dff73e7f314ec"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}